Apply now: feature your voice in our cell & gene therapy series
Cell and gene therapies are transforming rare disease treatment, offering new hope where options were once limited. But how do they work, and what choices exist for your community?
We're launching a special content series to help our 15k+ readers navigate this evolving landscape – and we need your voice!
In a case reported by Gunchenko et al. (2025), a patient who experienced hepatitis caused by the Epstein-Barr virus (EBV) went on to develop multiple autoimmune conditions, including aplastic anaemia, pernicious anaemia, and autoimmune thyroiditis. The patient's treatment involved an immunosuppressive regimen, which led to a gradual improvement in their blood cell counts (pancytopenia) and thyroid condition.
This case underscores the need for doctors to thoroughly evaluate and monitor patients after an EBV infection, as it can lead to serious autoimmune diseases. Early recognition and treatment of these conditions are crucial and can be life-saving. Gunchenko et al. emphasize the importance of vigilance following EBV infections to prevent and manage potential autoimmune complications effectively.
More Info 
Add to Calendar